Ecovyst, Inc. (ECVT)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$10.210.00%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Ecovyst aims for $890M-$970M revenue in 2026. Free cash flow target is $40M-$55M. The company invests $80M-$90M in capital spending. It leads in sustainable industrial catalysts.
The company is loss-making and management is volatile. Capital spending may pressure cash flow. A weak sector and market selloff risk growth.
The price is about 1% below our fair value near $12. Analysts expect 17% revenue growth. We see risk from volatile management and sector headwinds.
Breaks if: Capital spending falls below $80M or rises above $90M in FY26
Breaks if: Adjusted free cash flow falls below $40M in FY26
Breaks if: Revenue falls below $890M in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story within the Materials sector. ECVT is currently loss-making but is focused on increasing revenue and cash flow, with management showing a commitment to disciplined capital allocation.
The market appears to have priced in a justified valuation, suggesting that ECVT is seen as cheap compared to its peers. There is a slight expectations gap, indicating that investors may not fully anticipate the potential for revenue growth and sector momentum.
Management is on track to meet its revenue and capital expenditure targets for 2026, with recent results showing a significant revenue increase. However, the adjusted free cash flow target has a mixed outlook, reflecting some uncertainty in cash flow generation.
The thesis will depend on ECVT's ability to maintain its revenue growth and manage costs effectively. Additionally, the performance of sector bellwethers and inflation trends will be critical in shaping the broader market environment for ECVT.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports the revenue growth objective. The company aims to increase revenue to $1.02 billion to $1.06 billion in 2026. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, ECVT's trajectory will be influenced by its operational execution and external market factors. Not investment advice.